Maternal Obesity

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-02-13
Clinical Trial Update: Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy Outcomes [EARLY_Phase 1]
An early-phase 1 trial evaluating pyrroloquinoline quinone (PQQ) for improving outcomes in maternal obesity has been withdrawn.